100
Participants
Start Date
March 14, 2023
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2029
AV-1451
This is a cross-sectional study using the radiotracer AV-1451 to determine the relationship of tau pathology to other biomarker data of MPC participants.
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Massachusetts General Hospital, Boston
Massachusetts General Hospital
OTHER
University of Pennsylvania
OTHER